We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation
AGTC

Delisted

AGTC was delisted on the 30th of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Applied Genetic Technologies Corporation in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 45 → 0 (-45)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $3.34M → $0 (-$3.34M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 45

Holders
–
Holders Change
-45
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
45
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Portolan Capital Management
Massachusetts
-$435K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$401K
3
Millennium Management
Millennium Management
New York
-$395K
4
IVM
InterWest Venture Management
California
-$381K
5
KCM
Kingdon Capital Management
New York
-$333K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Portolan Capital Management
Massachusetts
– -$435K -1,600,902 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$401K -1,477,636 Closed
Millennium Management
3
Millennium Management
New York
– -$395K -1,455,882 Closed
IVM
4
InterWest Venture Management
California
– -$381K -1,404,515 Closed
KCM
5
Kingdon Capital Management
New York
– -$333K -1,225,000 Closed
Renaissance Technologies
6
Renaissance Technologies
New York
– -$309K -1,137,508 Closed
BlackRock
7
BlackRock
New York
– -$249K -918,381 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
– -$188K -694,798 Closed
CG
9
Colony Group
Massachusetts
– -$120K -442,619 Closed
Citadel Advisors
10
Citadel Advisors
Florida
– -$115K -423,709 Closed
Wells Fargo
11
Wells Fargo
California
– -$70K -257,083 Closed
State Street
12
State Street
Massachusetts
– -$34K -127,015 Closed
VF
13
Virtu Financial
New York
– -$32K -116,488 Closed
Ameriprise
14
Ameriprise
Minnesota
– -$31K -115,100 Closed
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
– -$30K -108,680 Closed
Two Sigma Advisers
16
Two Sigma Advisers
New York
– -$28K -104,749 Closed
Stifel Financial
17
Stifel Financial
Missouri
– -$25K -90,269 Closed
Two Sigma Investments
18
Two Sigma Investments
New York
– -$22K -80,397 Closed
Northern Trust
19
Northern Trust
Illinois
– -$20K -75,255 Closed
UBS Group
20
UBS Group
Switzerland
– -$16K -58,766 Closed
Assenagon Asset Management
21
Assenagon Asset Management
Luxembourg
– -$15K -55,699 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$14K -51,626 Closed
FT
23
Fiduciary Trust
Massachusetts
– -$11K -40,000 Closed
KAS
24
Kestra Advisory Services
Texas
– -$9K -33,800 Closed
Bank of New York Mellon
25
Bank of New York Mellon
New York
– -$8K -30,024 Closed
1
2

AGTC Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2022, worth a combined $0 — down 100% from $3.34M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of AGTC and 0 opened new positions — a net loss of 45 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Portolan Capital Management, exiting entirely with an estimated $435K sold.

  • 0 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2022, down from 45 in Q3 2022.
  • Funds reported $0 of Applied Genetic Technologies Corporation stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Applied Genetic Technologies Corporation positions in Q4 2022 and 45 closed out, a net change of -45 holders.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2022 was Portolan Capital Management, an estimated $435K sold.

Based on aggregated 13F filings for Q4 2022.